Clinical Trial Update: Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjunctive dobutamine for septic cardiomyopathy with tissue hypoperfusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Sepsis

Drugs mentioned

• Dobutamine (dobutamine)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Sepsis, Cardiomyopathies | Phase 3 | Status: COMPLETED